logo

For the Inventor, By the Inventor

Igoville, France

Jérôme Michel Claude Fortin

This inventor holds 22 USPTO granted patents and 1 published patent application and 10 EPO patents, primarily in Viral Infection Treatment. Top assignees: Janssen Pharmaceutica Nv, Janssen Sciences Ireland Uc, Janssen Sciences Ireland Unlimited Company. Active years: 2004-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jérôme Michel Claude Fortin. Retrieved from https://idiyas.com/inventor/jerome-michel-claude-fortin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 22 

% Patents Active = 68.2

 

Average Co-Inventor Count = 5.5

ph-index = 4

Forward Citations = 66(Granted Patents)


Location History:

  • Lery, FR (2004 - 2005)
  • Igoville, FR (2008 - 2023)
  • Issy-les-Moulineaux, FR (2022 - 2023)

Company Filing History:

goldMedal5 out of 2,101 
 
Janssen Pharmaceutica Nv
 patents
silverMedal5 out of 111 
 
Janssen Sciences Ireland Uc
 patents
bronzeMedal4 out of 64 
 
Janssen Sciences Ireland Unlimited Company
 patents
4. 4 out of 67 
 
Tibotec Pharmaceuticals Ltd.
 patents
5. 2 out of 161 
 
Janssen Pharmaceuticals, Inc.
 patents
6. 2 out of 632 
 
Katholieke Universiteit Leuven
 patents
7. 1 out of 6 
 
Elanco Animal Health Ireland Limited
 patents
8. 1 out of 22 
 
Janssen Biopharma, Inc.
 patents
where one patent can have more than one assignee

Years Active: 2004-2023

Loading Chart...
Loading Chart...
Areas of Expertise:
Dengue Viral Replication
Macrocyclic Deaza-Purinones
Purine Derivatives
Viral Infections
Benzimidazole Derivatives
Respiratory Syncytial Virus
IL-5 Inhibitors
Pyrimidine Derivatives
22 patents (USPTO):Explore Patents
1. 11795149 - Substituted indoline derivatives as dengue viral replication inhibitors (2023-10-24),
2. 11702426 - Macrocyclic deaza-purinones for the treatment of viral infections (2023-07-18),
3. 11407715 - Substituted indoline derivatives as dengue viral replication inhibitors (2022-08-09),
4. 11312727 - Macrocyclic flu endonuclease inhibitors (2022-04-26),
5. 11104678 - Purine derivatives for the treatment of viral infections (2021-08-31),
6. 10829494 - Macrocyclic deaza-purinones for the treatment of viral infections (2020-11-10),
7. 10822349 - Macrocyclic purines for the treatment of viral infections (2020-11-03),
8. 10280180 - Macrocyclic purines for the treatment of viral infections (2019-05-07),
9. 10280167 - Purine derivatives for the treatment of viral infections (2019-05-07),
10. 10266543 - Macrocyclic deaza-purinones for the treatment of viral infections (2019-04-23),
11. 10221157 - Pyrimidine derivatives for the treatment of bacterial diseases (2019-03-05),
12. 9725432 - Pyrimidine derivatives for the treatment of bacterial diseases (2017-08-08),
13. 9556176 - Purine derivatives for the treatment of viral infections (2017-01-31),
14. 8883837 - Morpholinyl containing benzimidazoles as inhibitors of respiratory syncytial virus replication (2014-11-11),
15. 8497270 - Macrocyclic integrase inhibitors (2013-07-30),

Title: Jérôme Michel Claude Fortin - The Innovative Mind from Igoville

Introduction: Jérôme Michel Claude Fortin is a renowned inventor hailing from Igoville, France, known for his groundbreaking contributions to various technological fields.

Latest Patents: Jérôme Michel Claude Fortin holds several patents in the areas of renewable energy, sustainable agriculture, and advanced robotics, showcasing his diverse range of expertise.

Career Highlights: Throughout his illustrious career, Jérôme Michel Claude Fortin has worked with leading research institutions and universities to develop cutting-edge technologies that have revolutionized their respective industries.

Collaborations: Jérôme Michel Claude Fortin has collaborated with top companies and innovative startups to bring his inventions to the market, fostering a culture of innovation and progress.

Conclusion: Jérôme Michel Claude Fortin's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and entrepreneurs worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…